U.S. court orders new trial for damages in Medtronic patent case (Reuters)
SUMMARY
A federal appeals court overturns a $102M jury award to Medtronic in a long-running patent dispute with NuVasive pertaining to spinal implants.
A jury awarded damages to Medtronic in 2011 after it found that NuVasive's CoRoent XL implants, MaXcess II and III retractors and Helix mini anterior cervical plates violated three Medtronic patents.
The appeals panel upheld the jury's finding of liability but determined that the damage award was improper because Medtronic is not permitted to recover damages for lost profits or for the sale of conveyed products.
Medtronic has not commented on the situation.
(Reuters) - A U.S. appeals court on Monday ruled that a federal jury had erred in 2011 when it awarded medical technology company Medtronic Plc $101.2 million in a patent infringement case, and ordered a new trial to determine damages.
But the U.S. Court of Appeals for the Federal Circuit, the top U.S. patent appeals court, upheld the jury's finding that NuVasive Inc's spinal surgery devices had infringed Medtronic's spinal implant and surgical method patents.
Th...
